These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis. Gofton JP; O'Brien WM J Rheumatol Suppl; 1982; 8():169-72. PubMed ID: 6813480 [No Abstract] [Full Text] [Related]
27. [Multicenter double-blind comparison of auranofin and Tauredon]. Kaik B; Bröll H Wien Klin Wochenschr Suppl; 1984; 156():33-40. PubMed ID: 6442055 [TBL] [Abstract][Full Text] [Related]
28. Roentgenographic findings during auranofin treatment. Gofton JP; O'Brien W Am J Med; 1983 Dec; 75(6A):142-4. PubMed ID: 6419597 [TBL] [Abstract][Full Text] [Related]
29. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients. Walz DT; Griswold DE; DiMartino MJ; Bumbier EE J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684 [TBL] [Abstract][Full Text] [Related]
30. Auranofin versus placebo in the treatment of rheumatoid arthritis. Wenger ME; Alexander S; Bland JH; Blechman WJ Am J Med; 1983 Dec; 75(6A):123-7. PubMed ID: 6419593 [TBL] [Abstract][Full Text] [Related]
31. Auranofin (Ridaura). Med Lett Drugs Ther; 1985 Oct; 27(699):89-90. PubMed ID: 3932827 [No Abstract] [Full Text] [Related]
32. Auranofin: a new drug for rheumatoid arthritis. Abruzzo JL Ann Intern Med; 1986 Aug; 105(2):274-6. PubMed ID: 3089090 [No Abstract] [Full Text] [Related]
33. Auranofin: dose-related risk to benefit. Weiss TE Am J Med; 1983 Dec; 75(6A):128-32. PubMed ID: 6419594 [TBL] [Abstract][Full Text] [Related]
34. Auranofin in the treatment of rheumatoid arthritis. A two-year study. Baldassare AR; Weiss TD; Arthur RE; Osborn TG; Moore TL; Zuckner J Mo Med; 1985 Nov; 82(11):711-5. PubMed ID: 3934512 [No Abstract] [Full Text] [Related]
35. [Auranofin in the treatment of chronic polyarthritis. Results of an open multicenter study]. Siegmeth W Wien Klin Wochenschr Suppl; 1984; 156():27-33. PubMed ID: 6442053 [TBL] [Abstract][Full Text] [Related]
36. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis]. Atakhodzhaeva ZA; Sigidin IaA Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906 [TBL] [Abstract][Full Text] [Related]
37. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887 [TBL] [Abstract][Full Text] [Related]
38. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report. Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485 [TBL] [Abstract][Full Text] [Related]
39. Auranofin and sodium aurothiomalate in the treatment of rheumatoid arthritis. A double-blind, comparative multicenter study. Schattenkirchner M; Kaik B; Muller-Fassbender H; Rau R; Zeidler H J Rheumatol Suppl; 1982; 8():184-9. PubMed ID: 6813483 [TBL] [Abstract][Full Text] [Related]